Showing 19,501 - 19,520 results of 20,793 for search '"Therapy"', query time: 0.11s Refine Results
  1. 19501

    Recent Nanotechnological Trends in the Management of Microbial Keratitis by Shraddha Jaiswal, Prabhavati Shinde, Vidya Tale

    Published 2024-12-01
    “…The failure and ineffectiveness of current therapies have necessitated the development of novel therapeutic strategies to manage MK. …”
    Get full text
    Article
  2. 19502
  3. 19503

    Circulatory shock in adults in emergency department by Ashok Kumar Pannu

    Published 2023-07-01
    “…., amount of initial fluids and steroids) and emerging (e.g., angiotensin II) therapies. Knowledge gaps and wide variations persist in managing cardiogenic shock that needs urgent addressing to improve outcomes.…”
    Get full text
    Article
  4. 19504

    Early tolerance and late persistence as alternative drug responses in cancer by Simona Punzi, Davide Cittaro, Guido Gatti, Gemma Crupi, Oronza A. Botrugno, Antonino Alex Cartalemi, Alon Gutfreund, Caterina Oneto, Valentina Giansanti, Chiara Battistini, Giovanni Santacatterina, Lucrezia Patruno, Ilaria Villanti, Martina Palumbo, Daniel J. Laverty, Francesca Giannese, Alex Graudenzi, Giulio Caravagna, Marco Antoniotti, Zachary Nagel, Ugo Cavallaro, Luisa Lanfrancone, Timothy A. Yap, Giulio Draetta, Nathalie Balaban, Giovanni Tonon

    Published 2025-02-01
    “…We conclude that exposing cancer cells to relevant standard-of-care antitumour therapies induces a pervasive drug-induced tolerant response that might be broadly exploited to increase the impact of first-line, adjuvant treatments and debulking in advanced cancers.…”
    Get full text
    Article
  5. 19505

    Pregnancy after kidney and liver transplantation by A Wise, N E Diana, B Bobat, R T Saggers, S Bhoora, S Budhram, L Chauke, V G Lala, A Mahomed, D Mokgoko, M Seabi, B Moore, S Naidoo, R B Nyakoe, N Odell, G Paget, L Wium, J Zamparini

    Published 2024-04-01
    “…It also explores the safety of and potential complications associated with specific immunosuppressive therapies during pregnancy. Further research is needed to enhance our understanding and optimise the management of these high-risk pregnancies in SA. …”
    Get full text
    Article
  6. 19506

    Improvement in the prediction power of an astrocyte genome-scale metabolic model using multi-omic data by Andrea Angarita-Rodríguez, Andrea Angarita-Rodríguez, Andrea Angarita-Rodríguez, Nicolás Mendoza-Mejía, Nicolás Mendoza-Mejía, Janneth González, Jason Papin, Jason Papin, Jason Papin, Andrés Felipe Aristizábal, Andrés Pinzón

    Published 2025-01-01
    “…This method facilitates the reconstruction of context-specific models grounded in multi-omics data, enhancing their biological relevance and predictive capacity.ResultsUsing this approach, we successfully reconstructed an astrocyte GEM with improved prediction capabilities compared to state-of-the-art models available in the literature.DiscussionThese advancements underscore the potential of multi-omic inte-gration to refine metabolic modeling and its critical role in studying neurodegeneration and developing effective therapies.…”
    Get full text
    Article
  7. 19507

    Emotional and Motivational Pain Processing: Current State of Knowledge and Perspectives in Translational Research by Susanne Becker, Edita Navratilova, Frauke Nees, Stefaan Van Damme

    Published 2018-01-01
    “…Finally, we discuss how translational approaches incorporating results from both human and animal investigations may aid in accelerating the discovery of therapies.…”
    Get full text
    Article
  8. 19508

    A Case of Disseminated Hypopigmented Keratoses Improved with Oral Acitretin by Ali Haydar Eskiocak, Cumhur İbrahim Bassorgun, Sarp Uzun, Soner Uzun

    Published 2017-01-01
    “…So far, only topical therapies have been used with failure in the previously reported cases except one patient. …”
    Get full text
    Article
  9. 19509

    Artificial intelligence in kidney transplantation: a 30-year bibliometric analysis of research trends, innovations, and future directions by Ying Jia He, Pin Lin Liu, Tao Wei, Tao Liu, Yi Fei Li, Jing Yang, Wen Xing Fan

    Published 2025-12-01
    “…Key research themes include AI-driven advancements in donor matching, deep learning for post-transplant monitoring, and machine learning algorithms for personalized immunosuppressive therapies. The findings underscore a rapid expansion in AI applications since 2017, with emerging trends in personalized medicine, multimodal data fusion, and telehealth. …”
    Get full text
    Article
  10. 19510

    Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer by L. S. Franco, S. Arunachalam, A. Chauhan, S. A. Kareff, P. L. Hallenbeck

    Published 2025-01-01
    “…As such, TEM8 has been identified as the target of novel oncologic therapies. It is especially attractive given its selective expression on the surface of solid tumor cells and associated stromal cells, such as cancer stem cells, invasive cancer cells, and immune cells, such as macrophages, angiogenic endothelial cells, pericytes, and cancer-associated fibroblasts. …”
    Get full text
    Article
  11. 19511

    Herpes Simplex Virus Latency: The DNA Repair-Centered Pathway by Jay C. Brown

    Published 2017-01-01
    “…Although latency suggests itself as an attractive target for novel anti-HSV1 therapies, progress in their development has been slowed due in part to a lack of agreement about the basic biochemical mechanisms involved. …”
    Get full text
    Article
  12. 19512

    Chemokines and Neurodegeneration in the Early Stage of Experimental Ischemic Stroke by Pawel Wolinski, Andrzej Glabinski

    Published 2013-01-01
    “…Upregulated in the ischemic brain chemokines may be a potential target for future therapies reducing inflammatory cell migration to the brain in early stroke. …”
    Get full text
    Article
  13. 19513

    Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes by Hassan Al Thani, Ayman El-Menyar, Khalid F. AlHabib, Ahmed Al-Motarreb, Ahmad Hersi, Hussam AlFaleh, Nidal Asaad, Shukri Al Saif, Wael Almahmeed, Kadhim Sulaiman, Haitham Amin, Alawi A. Alsheikh-Ali, Khalid AlNemer, Jassim Al Suwaidi

    Published 2012-01-01
    “…They were less likely to receive evidence-based therapies. Diabetes mellitus, renal failure, and hypertension were independent predictors for presence of PolyVD. …”
    Get full text
    Article
  14. 19514
  15. 19515
  16. 19516
  17. 19517

    Genetic Determinants of Osteoporosis: Common Bases to Cardiovascular Diseases? by Francesca Marini, Maria Luisa Brandi

    Published 2010-01-01
    “…The individuation of genetic factors responsible for osteoporosis predisposition and development is fundamental for the disease prevention and for the setting of novel therapies, before fracture occurrence. In the last decades the interest of the Scientific Community has been concentrated in the understanding the genetic bases of this disease but with controversial and/or inconclusive results. …”
    Get full text
    Article
  18. 19518

    Probing Neural Transplant Networks In Vivo with Optogenetics and Optogenetic fMRI by Andrew J. Weitz, Jin Hyung Lee

    Published 2016-01-01
    “…This review summarizes the efforts in stem cell biology and neuroimaging that made this development possible and outlines its potential applications for improving and optimizing stem cell-based therapies in the future.…”
    Get full text
    Article
  19. 19519

    Successful Management of Immune Thrombocytopenia Presenting with Lethal Alveolar Hemorrhage by Keiki Nagaharu, Masahiro Masuya, Keiki Kawakami, Naoyuki Katayama

    Published 2019-01-01
    “…These patients recovered following treatment with romiplostim at a higher dose (10 μg/kg), in addition to conventional therapies including corticosteroids and high-dose intravenous immunoglobulin. …”
    Get full text
    Article
  20. 19520

    An Optimized Protocol for Simultaneous Propagation of Patient-derived Organoids and Matching CAFs by Jenny Högström, Taru Muranen

    Published 2025-01-01
    “…Recurrence and resistance to targeted therapies have been difficult to study due to the long clinical course of the disease, the complex nature of resistance, and the lack of clinically relevant model systems. …”
    Get full text
    Article